GRP
RNAM

Global Retirement Partners’s Avidity Biosciences RNAM Stock Holding History

Global Retirement Partners’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.1K Sell
210
-24
-10% -$1.55K ﹤0.01% 2988
2025
Q3 		$10.2K Sell
234
-466
-67% -$18.8K ﹤0.01% 2691
2025
Q2 		$19.9K Buy
+700
New +$20.9K ﹤0.01% 2300
2024
Q4 		$5.82K Hold
200
– – ﹤0.01% 2625
2024
Q3 		$9.19K Sell
200
-400
-67% -$17.4K ﹤0.01% 2324
2024
Q2 		$24.5K Buy
+600
New +$17.2K ﹤0.01% 1882

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Retirement Partners's RNAM Position: Q4 2025 in Review

Global Retirement Partners reduced its Avidity Biosciences (RNAM) stake by 10% in Q4 2025, selling an estimated $1.55K and leaving 210 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Global Retirement Partners first reported a position in RNAM in Q2 2024 and has held it in 6 quarters since. The position peaked at $24.5K in Q2 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Global Retirement Partners held 210 shares of Avidity Biosciences worth $15.1K as of Q4 2025.
  • Global Retirement Partners sold 24 Avidity Biosciences shares in Q4 2025, an estimated $1.55K.
  • Avidity Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2988 holding.
  • Global Retirement Partners first reported a position in Avidity Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Global Retirement Partners's Avidity Biosciences position peaked at $24.5K in Q2 2024.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.